Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aggression | 109 | 2023 | 320 | 30.620 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 80 | 2023 | 276 | 27.940 |
Why?
|
Personality Disorders | 52 | 2022 | 146 | 13.830 |
Why?
|
Impulsive Behavior | 52 | 2023 | 281 | 11.740 |
Why?
|
Anger | 25 | 2023 | 78 | 6.180 |
Why?
|
Emotions | 23 | 2022 | 341 | 4.970 |
Why?
|
Serotonin | 18 | 2015 | 218 | 4.150 |
Why?
|
Adult | 134 | 2023 | 25648 | 3.900 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 30 | 2021 | 216 | 3.830 |
Why?
|
Psychiatric Status Rating Scales | 35 | 2019 | 487 | 2.940 |
Why?
|
Emotional Intelligence | 6 | 2017 | 22 | 2.880 |
Why?
|
Male | 131 | 2022 | 40965 | 2.780 |
Why?
|
Young Adult | 51 | 2020 | 5976 | 2.690 |
Why?
|
Social Perception | 9 | 2022 | 95 | 2.520 |
Why?
|
Personality | 6 | 2022 | 134 | 2.520 |
Why?
|
Female | 122 | 2022 | 44532 | 2.500 |
Why?
|
Psychometrics | 13 | 2022 | 327 | 2.480 |
Why?
|
Humans | 166 | 2023 | 86643 | 2.470 |
Why?
|
Self-Injurious Behavior | 10 | 2019 | 105 | 2.410 |
Why?
|
Hostility | 7 | 2021 | 24 | 2.290 |
Why?
|
Borderline Personality Disorder | 10 | 2020 | 33 | 2.100 |
Why?
|
Amygdala | 5 | 2021 | 84 | 2.070 |
Why?
|
Stress Disorders, Post-Traumatic | 5 | 2022 | 96 | 1.970 |
Why?
|
Surveys and Questionnaires | 17 | 2023 | 2501 | 1.970 |
Why?
|
Middle Aged | 65 | 2020 | 25028 | 1.960 |
Why?
|
Inflammation | 7 | 2023 | 920 | 1.640 |
Why?
|
Fluoxetine | 4 | 2015 | 42 | 1.590 |
Why?
|
Suicide, Attempted | 7 | 2018 | 129 | 1.590 |
Why?
|
Comorbidity | 19 | 2020 | 943 | 1.580 |
Why?
|
Antisocial Personality Disorder | 6 | 2022 | 91 | 1.550 |
Why?
|
Substance-Related Disorders | 4 | 2019 | 394 | 1.450 |
Why?
|
Feeding and Eating Disorders | 3 | 2019 | 173 | 1.450 |
Why?
|
C-Reactive Protein | 7 | 2023 | 190 | 1.410 |
Why?
|
Brain Concussion | 2 | 2022 | 59 | 1.400 |
Why?
|
Social Behavior | 6 | 2018 | 294 | 1.360 |
Why?
|
Adolescent | 30 | 2023 | 8981 | 1.330 |
Why?
|
Endocannabinoids | 2 | 2019 | 27 | 1.330 |
Why?
|
Depressive Disorder, Major | 4 | 2019 | 158 | 1.320 |
Why?
|
Frontal Lobe | 4 | 2017 | 130 | 1.290 |
Why?
|
Growth Hormone | 3 | 2015 | 97 | 1.290 |
Why?
|
Kynurenine | 2 | 2019 | 20 | 1.270 |
Why?
|
Affect | 4 | 2018 | 386 | 1.230 |
Why?
|
Affective Symptoms | 3 | 2018 | 47 | 1.220 |
Why?
|
Interleukin-6 | 6 | 2023 | 256 | 1.190 |
Why?
|
Homovanillic Acid | 4 | 2012 | 35 | 1.150 |
Why?
|
Anxiety Disorders | 6 | 2023 | 148 | 1.150 |
Why?
|
Personality Inventory | 9 | 2015 | 108 | 1.140 |
Why?
|
Hydrocortisone | 3 | 2023 | 298 | 1.130 |
Why?
|
Violence | 3 | 2021 | 143 | 1.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 1373 | 1.100 |
Why?
|
Facial Recognition | 2 | 2016 | 15 | 1.090 |
Why?
|
Prefrontal Cortex | 4 | 2020 | 129 | 1.050 |
Why?
|
Mood Disorders | 2 | 2018 | 81 | 1.040 |
Why?
|
Severity of Illness Index | 10 | 2020 | 1801 | 0.980 |
Why?
|
Facial Expression | 3 | 2010 | 51 | 0.980 |
Why?
|
Tryptophan | 3 | 2016 | 90 | 0.980 |
Why?
|
Child Abuse | 4 | 2020 | 78 | 0.970 |
Why?
|
Magnetic Resonance Imaging | 13 | 2022 | 3362 | 0.970 |
Why?
|
Statistics as Topic | 7 | 2015 | 238 | 0.950 |
Why?
|
Interpersonal Relations | 4 | 2016 | 170 | 0.940 |
Why?
|
Clonidine | 2 | 2015 | 37 | 0.920 |
Why?
|
Suicidal Ideation | 5 | 2016 | 67 | 0.900 |
Why?
|
Paroxetine | 4 | 2011 | 26 | 0.880 |
Why?
|
Parental Death | 1 | 2022 | 1 | 0.880 |
Why?
|
Parent-Child Relations | 3 | 2015 | 77 | 0.870 |
Why?
|
Limbic System | 4 | 2012 | 23 | 0.860 |
Why?
|
Oxidative Stress | 3 | 2020 | 447 | 0.860 |
Why?
|
Hydroxyindoleacetic Acid | 3 | 2012 | 27 | 0.840 |
Why?
|
Spinal Puncture | 8 | 2015 | 38 | 0.840 |
Why?
|
Testosterone | 3 | 2017 | 271 | 0.840 |
Why?
|
Verbal Behavior | 2 | 2014 | 32 | 0.830 |
Why?
|
Personality Assessment | 7 | 2014 | 98 | 0.820 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 683 | 0.790 |
Why?
|
Cognition | 5 | 2022 | 570 | 0.790 |
Why?
|
Analysis of Variance | 11 | 2016 | 912 | 0.790 |
Why?
|
Brain | 8 | 2016 | 2216 | 0.780 |
Why?
|
Awareness | 2 | 2018 | 93 | 0.770 |
Why?
|
Caffeine | 1 | 2021 | 81 | 0.770 |
Why?
|
Self-Assessment | 2 | 2011 | 47 | 0.770 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 196 | 0.760 |
Why?
|
Suicide | 2 | 2016 | 139 | 0.760 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 45 | 0.760 |
Why?
|
Twins | 3 | 2017 | 65 | 0.750 |
Why?
|
Case-Control Studies | 10 | 2016 | 1805 | 0.730 |
Why?
|
Receptors, Cannabinoid | 1 | 2019 | 4 | 0.720 |
Why?
|
Brain Mapping | 9 | 2021 | 548 | 0.690 |
Why?
|
Benzazepines | 1 | 2019 | 89 | 0.690 |
Why?
|
Alcoholism | 2 | 2020 | 172 | 0.670 |
Why?
|
Neurotransmitter Agents | 3 | 2013 | 106 | 0.670 |
Why?
|
Social Desirability | 1 | 2018 | 12 | 0.670 |
Why?
|
Sex Factors | 8 | 2021 | 1054 | 0.670 |
Why?
|
Bipolar Disorder | 3 | 2019 | 377 | 0.660 |
Why?
|
Deception | 1 | 2018 | 20 | 0.660 |
Why?
|
Valproic Acid | 3 | 2015 | 24 | 0.660 |
Why?
|
Adult Survivors of Child Abuse | 2 | 2015 | 10 | 0.650 |
Why?
|
Depressive Disorder | 1 | 2019 | 218 | 0.650 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2012 | 183 | 0.640 |
Why?
|
Reproducibility of Results | 10 | 2023 | 2705 | 0.640 |
Why?
|
Deoxyguanosine | 2 | 2015 | 28 | 0.620 |
Why?
|
Gray Matter | 1 | 2017 | 33 | 0.620 |
Why?
|
Health Status | 3 | 2010 | 360 | 0.620 |
Why?
|
Neuropsychological Tests | 7 | 2016 | 502 | 0.610 |
Why?
|
Biomarkers | 8 | 2016 | 1718 | 0.600 |
Why?
|
Pilot Projects | 6 | 2022 | 839 | 0.600 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 1621 | 0.590 |
Why?
|
Perforant Pathway | 1 | 2016 | 6 | 0.570 |
Why?
|
Defense Mechanisms | 1 | 2016 | 7 | 0.560 |
Why?
|
Prevalence | 8 | 2020 | 1239 | 0.560 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 6 | 0.560 |
Why?
|
Overweight | 1 | 2017 | 118 | 0.550 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2006 | 44 | 0.550 |
Why?
|
Oxytocin | 2 | 2009 | 71 | 0.550 |
Why?
|
Stress, Psychological | 3 | 2020 | 313 | 0.540 |
Why?
|
Models, Psychological | 3 | 2015 | 157 | 0.540 |
Why?
|
Citalopram | 1 | 2015 | 20 | 0.530 |
Why?
|
Toxoplasmosis | 1 | 2016 | 64 | 0.530 |
Why?
|
Receptors, Interleukin-1 Type II | 1 | 2015 | 3 | 0.530 |
Why?
|
White Matter | 1 | 2016 | 80 | 0.520 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 567 | 0.520 |
Why?
|
Self-Control | 1 | 2015 | 10 | 0.520 |
Why?
|
Self Report | 5 | 2021 | 288 | 0.510 |
Why?
|
Psychotropic Drugs | 1 | 2015 | 75 | 0.510 |
Why?
|
Inflammation Mediators | 1 | 2015 | 154 | 0.500 |
Why?
|
Object Attachment | 1 | 2014 | 20 | 0.500 |
Why?
|
Dinoprost | 1 | 2014 | 26 | 0.490 |
Why?
|
Aged | 15 | 2019 | 18415 | 0.490 |
Why?
|
Blood Platelets | 2 | 2011 | 149 | 0.480 |
Why?
|
Pituitary-Adrenal System | 2 | 2023 | 64 | 0.480 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2016 | 332 | 0.470 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2023 | 81 | 0.470 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 479 | 0.470 |
Why?
|
Wounds and Injuries | 2 | 2015 | 231 | 0.460 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2013 | 46 | 0.460 |
Why?
|
Child Behavior Disorders | 1 | 2013 | 76 | 0.460 |
Why?
|
DNA Methylation | 1 | 2018 | 628 | 0.450 |
Why?
|
Fluorobenzenes | 1 | 2012 | 33 | 0.440 |
Why?
|
Glutamic Acid | 1 | 2013 | 152 | 0.440 |
Why?
|
Neuropeptide Y | 1 | 2012 | 31 | 0.440 |
Why?
|
Sulfides | 1 | 2012 | 68 | 0.440 |
Why?
|
Aniline Compounds | 1 | 2012 | 55 | 0.440 |
Why?
|
Internal-External Control | 2 | 2009 | 44 | 0.440 |
Why?
|
Mental Processes | 1 | 2012 | 31 | 0.430 |
Why?
|
Hyperkinesis | 1 | 2012 | 15 | 0.430 |
Why?
|
Substance P | 1 | 2012 | 61 | 0.420 |
Why?
|
Radioligand Assay | 1 | 2011 | 32 | 0.420 |
Why?
|
Receptors, Serotonin, 5-HT2 | 1 | 2011 | 15 | 0.410 |
Why?
|
Neurotic Disorders | 1 | 2011 | 13 | 0.410 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2011 | 83 | 0.410 |
Why?
|
Hippocampus | 1 | 2015 | 442 | 0.410 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 180 | 0.410 |
Why?
|
Harm Reduction | 1 | 2011 | 16 | 0.410 |
Why?
|
Reaction Time | 5 | 2012 | 309 | 0.410 |
Why?
|
Quality of Life | 2 | 2018 | 1585 | 0.410 |
Why?
|
Psychological Tests | 4 | 2017 | 91 | 0.400 |
Why?
|
Double-Blind Method | 7 | 2015 | 1823 | 0.400 |
Why?
|
Diseases in Twins | 1 | 2011 | 65 | 0.400 |
Why?
|
Piperidines | 1 | 2012 | 181 | 0.400 |
Why?
|
Linear Models | 4 | 2016 | 421 | 0.400 |
Why?
|
GABA-B Receptor Agonists | 1 | 2010 | 5 | 0.390 |
Why?
|
Receptors, GABA-B | 1 | 2010 | 7 | 0.390 |
Why?
|
Depression | 4 | 2019 | 473 | 0.390 |
Why?
|
Baclofen | 1 | 2010 | 15 | 0.390 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2010 | 4 | 0.380 |
Why?
|
Synapses | 1 | 2012 | 265 | 0.380 |
Why?
|
Cerebral Cortex | 2 | 2012 | 584 | 0.370 |
Why?
|
Nervous System | 1 | 2011 | 86 | 0.370 |
Why?
|
Family Health | 1 | 2010 | 162 | 0.360 |
Why?
|
Bariatric Surgery | 1 | 2012 | 194 | 0.360 |
Why?
|
Pyrimidines | 2 | 2010 | 370 | 0.360 |
Why?
|
Obesity, Morbid | 1 | 2012 | 225 | 0.350 |
Why?
|
Synaptic Transmission | 1 | 2011 | 222 | 0.350 |
Why?
|
Cohort Studies | 6 | 2019 | 2767 | 0.350 |
Why?
|
Interview, Psychological | 2 | 2012 | 69 | 0.350 |
Why?
|
Smoking | 2 | 2011 | 609 | 0.340 |
Why?
|
Analgesics | 1 | 2010 | 119 | 0.340 |
Why?
|
Amino Acids, Neutral | 1 | 2008 | 3 | 0.340 |
Why?
|
Spouse Abuse | 1 | 2008 | 13 | 0.340 |
Why?
|
Cues | 2 | 2012 | 175 | 0.340 |
Why?
|
Glycerides | 2 | 2019 | 17 | 0.340 |
Why?
|
Arachidonic Acids | 2 | 2019 | 39 | 0.340 |
Why?
|
Alcoholic Intoxication | 1 | 2009 | 31 | 0.330 |
Why?
|
Aging | 1 | 2013 | 691 | 0.330 |
Why?
|
Psychotherapy, Group | 1 | 2008 | 33 | 0.330 |
Why?
|
Arousal | 1 | 2009 | 170 | 0.330 |
Why?
|
Self Concept | 5 | 2012 | 133 | 0.320 |
Why?
|
Picolinic Acids | 2 | 2019 | 5 | 0.320 |
Why?
|
Fenfluramine | 2 | 2010 | 20 | 0.320 |
Why?
|
Norepinephrine | 2 | 2011 | 167 | 0.320 |
Why?
|
Universities | 2 | 2021 | 135 | 0.320 |
Why?
|
Anxiety | 4 | 2023 | 287 | 0.310 |
Why?
|
United States | 7 | 2020 | 6672 | 0.300 |
Why?
|
Exploratory Behavior | 1 | 2007 | 44 | 0.300 |
Why?
|
Self Care | 2 | 2020 | 164 | 0.300 |
Why?
|
Twin Studies as Topic | 1 | 2006 | 19 | 0.300 |
Why?
|
Child | 9 | 2020 | 6927 | 0.300 |
Why?
|
Brain Injuries | 1 | 2009 | 161 | 0.290 |
Why?
|
Parents | 2 | 2023 | 272 | 0.280 |
Why?
|
Ethanol | 1 | 2009 | 249 | 0.280 |
Why?
|
Psychiatric Department, Hospital | 1 | 2005 | 4 | 0.280 |
Why?
|
Schizotypal Personality Disorder | 1 | 2005 | 6 | 0.260 |
Why?
|
Electroshock | 3 | 2009 | 17 | 0.260 |
Why?
|
Mental Disorders | 4 | 2016 | 371 | 0.260 |
Why?
|
Serotonin Receptor Agonists | 2 | 2019 | 15 | 0.250 |
Why?
|
Visual Perception | 1 | 2008 | 319 | 0.250 |
Why?
|
Ambulatory Care | 1 | 2005 | 181 | 0.240 |
Why?
|
Pennsylvania | 3 | 2016 | 75 | 0.240 |
Why?
|
Temporal Lobe | 1 | 2005 | 172 | 0.240 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 2003 | 18 | 0.240 |
Why?
|
Administration, Oral | 3 | 2010 | 684 | 0.230 |
Why?
|
Neural Pathways | 3 | 2011 | 308 | 0.220 |
Why?
|
Interleukin-8 | 1 | 2023 | 86 | 0.220 |
Why?
|
Happiness | 2 | 2016 | 12 | 0.220 |
Why?
|
Risk Factors | 5 | 2015 | 5417 | 0.220 |
Why?
|
Neuroticism | 1 | 2022 | 5 | 0.220 |
Why?
|
Intelligence Tests | 2 | 2014 | 38 | 0.220 |
Why?
|
Firearms | 1 | 2023 | 48 | 0.220 |
Why?
|
Psychopathology | 1 | 2022 | 29 | 0.220 |
Why?
|
Research Subjects | 1 | 2023 | 73 | 0.210 |
Why?
|
Logistic Models | 3 | 2010 | 1186 | 0.210 |
Why?
|
Psychophysiologic Disorders | 1 | 2021 | 7 | 0.210 |
Why?
|
Crime | 2 | 2006 | 36 | 0.210 |
Why?
|
Psychotherapy | 1 | 2022 | 74 | 0.210 |
Why?
|
Radionuclide Imaging | 2 | 2012 | 220 | 0.210 |
Why?
|
Attention | 3 | 2017 | 388 | 0.200 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 567 | 0.200 |
Why?
|
Behavior Therapy | 1 | 2022 | 75 | 0.200 |
Why?
|
Phobic Disorders | 2 | 2012 | 13 | 0.200 |
Why?
|
Photic Stimulation | 2 | 2016 | 493 | 0.200 |
Why?
|
Dopamine | 2 | 2015 | 275 | 0.200 |
Why?
|
Age Factors | 4 | 2019 | 1851 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 3 | 2012 | 238 | 0.200 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 819 | 0.200 |
Why?
|
Behavior Control | 1 | 2020 | 4 | 0.190 |
Why?
|
Twins, Dizygotic | 3 | 2012 | 40 | 0.190 |
Why?
|
Twins, Monozygotic | 3 | 2012 | 57 | 0.190 |
Why?
|
Time Factors | 5 | 2010 | 5210 | 0.190 |
Why?
|
Follow-Up Studies | 4 | 2012 | 3640 | 0.190 |
Why?
|
Parenting | 2 | 2015 | 67 | 0.190 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 364 | 0.190 |
Why?
|
Healthy Volunteers | 1 | 2021 | 143 | 0.190 |
Why?
|
Nicotine | 1 | 2021 | 194 | 0.180 |
Why?
|
Hope | 1 | 2019 | 4 | 0.180 |
Why?
|
Social Class | 1 | 2020 | 128 | 0.180 |
Why?
|
Classification | 1 | 2019 | 54 | 0.170 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 1673 | 0.160 |
Why?
|
Polyunsaturated Alkamides | 1 | 2018 | 6 | 0.160 |
Why?
|
Work | 1 | 2018 | 16 | 0.160 |
Why?
|
Anisotropy | 2 | 2016 | 62 | 0.160 |
Why?
|
Observer Variation | 3 | 2005 | 602 | 0.160 |
Why?
|
NF-kappa B | 1 | 2021 | 444 | 0.160 |
Why?
|
Reference Values | 3 | 2005 | 674 | 0.160 |
Why?
|
Health Surveys | 2 | 2017 | 239 | 0.160 |
Why?
|
Bias | 3 | 2012 | 127 | 0.150 |
Why?
|
Age of Onset | 4 | 2006 | 310 | 0.150 |
Why?
|
Sex Characteristics | 2 | 2012 | 319 | 0.150 |
Why?
|
Pain Measurement | 2 | 2009 | 321 | 0.150 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 307 | 0.150 |
Why?
|
Data Collection | 2 | 2012 | 372 | 0.150 |
Why?
|
Gene Expression | 1 | 2021 | 1284 | 0.150 |
Why?
|
Epigenomics | 1 | 2018 | 100 | 0.150 |
Why?
|
Recurrence | 1 | 2020 | 1139 | 0.150 |
Why?
|
Motion Pictures | 1 | 2016 | 11 | 0.150 |
Why?
|
Activities of Daily Living | 1 | 2018 | 204 | 0.150 |
Why?
|
Ecological Momentary Assessment | 1 | 2017 | 25 | 0.150 |
Why?
|
Kynurenic Acid | 1 | 2016 | 7 | 0.140 |
Why?
|
Quinolinic Acid | 1 | 2016 | 9 | 0.140 |
Why?
|
Sublimation, Psychological | 1 | 2016 | 2 | 0.140 |
Why?
|
Intelligence | 2 | 2009 | 71 | 0.140 |
Why?
|
Weight Gain | 1 | 2017 | 123 | 0.140 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 67 | 0.140 |
Why?
|
Irritable Mood | 1 | 2015 | 10 | 0.140 |
Why?
|
Risk | 1 | 2017 | 674 | 0.130 |
Why?
|
Serotonin Agents | 1 | 2015 | 12 | 0.130 |
Why?
|
Students | 1 | 2016 | 147 | 0.130 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 296 | 0.130 |
Why?
|
Life Change Events | 2 | 2005 | 48 | 0.130 |
Why?
|
Interleukins | 1 | 2015 | 134 | 0.130 |
Why?
|
Decision Making | 2 | 2011 | 642 | 0.130 |
Why?
|
Organ Size | 1 | 2015 | 364 | 0.120 |
Why?
|
Immunoglobulin G | 1 | 2016 | 456 | 0.120 |
Why?
|
Sertraline | 1 | 2012 | 7 | 0.110 |
Why?
|
Personality Tests | 1 | 2012 | 21 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 1204 | 0.110 |
Why?
|
Period Circadian Proteins | 1 | 2012 | 10 | 0.110 |
Why?
|
Treatment Outcome | 4 | 2011 | 7993 | 0.110 |
Why?
|
Adenosine Deaminase | 1 | 2012 | 20 | 0.110 |
Why?
|
Loneliness | 1 | 2012 | 24 | 0.110 |
Why?
|
Psychology | 1 | 2012 | 24 | 0.110 |
Why?
|
Biogenic Monoamines | 1 | 2012 | 8 | 0.110 |
Why?
|
Body Temperature | 2 | 2010 | 124 | 0.110 |
Why?
|
Radioimmunoassay | 1 | 2012 | 155 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 315 | 0.110 |
Why?
|
Behavioral Research | 1 | 2011 | 10 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 579 | 0.110 |
Why?
|
Tritium | 1 | 2011 | 133 | 0.100 |
Why?
|
Avoidance Learning | 1 | 2011 | 16 | 0.100 |
Why?
|
Prospective Studies | 2 | 2018 | 4213 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 508 | 0.100 |
Why?
|
Crime Victims | 1 | 2012 | 34 | 0.100 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2011 | 22 | 0.100 |
Why?
|
Amino Acids | 1 | 2012 | 252 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2012 | 137 | 0.100 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2010 | 2 | 0.100 |
Why?
|
Iodine Radioisotopes | 1 | 2011 | 134 | 0.100 |
Why?
|
Receptors, Neurotransmitter | 1 | 2011 | 25 | 0.100 |
Why?
|
Cytokines | 1 | 2015 | 776 | 0.100 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 297 | 0.100 |
Why?
|
Neuropeptides | 1 | 2011 | 112 | 0.090 |
Why?
|
Synaptic Membranes | 1 | 2010 | 14 | 0.090 |
Why?
|
Behavioral Symptoms | 1 | 2010 | 15 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 171 | 0.090 |
Why?
|
Obesity | 1 | 2017 | 963 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2010 | 244 | 0.090 |
Why?
|
Games, Experimental | 1 | 2009 | 10 | 0.090 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 1621 | 0.090 |
Why?
|
Chicago | 1 | 2014 | 1379 | 0.090 |
Why?
|
Dominance-Subordination | 1 | 2009 | 8 | 0.090 |
Why?
|
Empathy | 1 | 2011 | 147 | 0.090 |
Why?
|
Social Adjustment | 1 | 2009 | 46 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 916 | 0.090 |
Why?
|
Heart Rate | 1 | 2012 | 492 | 0.090 |
Why?
|
Dendrites | 1 | 2010 | 99 | 0.090 |
Why?
|
Competitive Behavior | 1 | 2009 | 28 | 0.090 |
Why?
|
Retrospective Studies | 1 | 2023 | 8489 | 0.090 |
Why?
|
Psychomotor Performance | 1 | 2012 | 492 | 0.090 |
Why?
|
Diet | 1 | 2012 | 443 | 0.080 |
Why?
|
Relaxation Therapy | 1 | 2008 | 4 | 0.080 |
Why?
|
Beverages | 1 | 2008 | 17 | 0.080 |
Why?
|
Capsules | 1 | 2008 | 38 | 0.080 |
Why?
|
Demography | 1 | 2009 | 177 | 0.080 |
Why?
|
Signal Transduction | 1 | 2019 | 3241 | 0.080 |
Why?
|
Fear | 2 | 2023 | 78 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2009 | 369 | 0.080 |
Why?
|
Central Nervous System Depressants | 1 | 2009 | 45 | 0.080 |
Why?
|
Pain Threshold | 1 | 2008 | 58 | 0.080 |
Why?
|
Individuality | 1 | 2009 | 109 | 0.080 |
Why?
|
Regression Analysis | 1 | 2010 | 596 | 0.080 |
Why?
|
Control Groups | 1 | 2008 | 15 | 0.080 |
Why?
|
Animals | 3 | 2020 | 26582 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2017 | 6509 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 122 | 0.080 |
Why?
|
Social Environment | 2 | 2010 | 188 | 0.080 |
Why?
|
Models, Statistical | 1 | 2011 | 574 | 0.080 |
Why?
|
Models, Neurological | 1 | 2011 | 405 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2008 | 157 | 0.080 |
Why?
|
Registries | 1 | 2011 | 702 | 0.080 |
Why?
|
Child Psychiatry | 1 | 2007 | 9 | 0.080 |
Why?
|
Prolactin | 2 | 2006 | 88 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 526 | 0.070 |
Why?
|
Genetic Linkage | 1 | 2008 | 623 | 0.070 |
Why?
|
Binding Sites | 1 | 2009 | 1098 | 0.070 |
Why?
|
Drug Therapy | 1 | 2007 | 70 | 0.070 |
Why?
|
Body Mass Index | 1 | 2010 | 770 | 0.070 |
Why?
|
Genome, Human | 1 | 2011 | 756 | 0.070 |
Why?
|
Risk-Taking | 1 | 2007 | 148 | 0.070 |
Why?
|
Rhode Island | 1 | 2005 | 9 | 0.070 |
Why?
|
Genotype | 2 | 2010 | 1851 | 0.070 |
Why?
|
Discriminant Analysis | 1 | 2005 | 66 | 0.070 |
Why?
|
Alcohol-Related Disorders | 1 | 2005 | 17 | 0.070 |
Why?
|
Subarachnoid Space | 1 | 2005 | 17 | 0.070 |
Why?
|
Hormones | 1 | 2006 | 141 | 0.070 |
Why?
|
Receptors, Serotonin | 1 | 2005 | 34 | 0.070 |
Why?
|
Receptors, Dopamine D3 | 1 | 2005 | 18 | 0.070 |
Why?
|
Sexual Maturation | 1 | 2005 | 35 | 0.060 |
Why?
|
Schizophrenia | 1 | 2008 | 464 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2005 | 57 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 92 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 1961 | 0.060 |
Why?
|
Baltimore | 1 | 2004 | 36 | 0.060 |
Why?
|
Anticonvulsants | 1 | 2005 | 126 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2005 | 329 | 0.060 |
Why?
|
Behavior | 1 | 2003 | 85 | 0.060 |
Why?
|
Radiography | 1 | 2005 | 813 | 0.060 |
Why?
|
Patient Selection | 1 | 2006 | 685 | 0.050 |
Why?
|
Patient Simulation | 1 | 2002 | 42 | 0.050 |
Why?
|
Narcissism | 1 | 2020 | 4 | 0.050 |
Why?
|
Biomedical Research | 1 | 2004 | 376 | 0.040 |
Why?
|
Pedigree | 2 | 2011 | 966 | 0.040 |
Why?
|
Geriatrics | 1 | 1979 | 61 | 0.040 |
Why?
|
Phenotype | 1 | 2005 | 2378 | 0.040 |
Why?
|
Child, Preschool | 1 | 2005 | 3612 | 0.040 |
Why?
|
Education, Medical | 1 | 1979 | 233 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2011 | 21 | 0.030 |
Why?
|
Finland | 1 | 2010 | 29 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 2357 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2010 | 55 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 77 | 0.020 |
Why?
|
Acute Disease | 1 | 2012 | 826 | 0.020 |
Why?
|
Founder Effect | 1 | 2010 | 104 | 0.020 |
Why?
|
Child Development | 1 | 2011 | 163 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 31 | 0.020 |
Why?
|
Orphan Nuclear Receptors | 1 | 2008 | 13 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 145 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2010 | 999 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2009 | 294 | 0.020 |
Why?
|
Gene Frequency | 1 | 2008 | 677 | 0.020 |
Why?
|
Cell Line | 1 | 2010 | 2468 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2010 | 1924 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2007 | 147 | 0.020 |
Why?
|
Placebos | 1 | 2005 | 218 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 1565 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 1920 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 2271 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 3968 | 0.010 |
Why?
|
Mice | 1 | 2010 | 11352 | 0.010 |
Why?
|
Curriculum | 1 | 1979 | 539 | 0.010 |
Why?
|